Article
Analysis of Humoral Immune Responses in Chikungunya Virus (CHIKV)-Infected Patients and Individuals Vaccinated With a Candidate CHIKV Vaccine
Registro en:
HENNS, Lisa et al. Analysis of Humoral Immune Responses in
Chikungunya Virus (CHIKV)-Infected Patients and
Individuals Vaccinated With a Candidate CHIKV
Vaccine. Journal of Infectious Diseases, v. 221, p. 1713-1723, 2020.
0022-1899
10.1093/infdis/jiz658
2537-6613
Autor
Henss, Lisa
Yue, Constanze
Von Rhein, Christine
Tschismarov, Roland
Lewis-Ximenez, Lia Laura
Dölle, Albert
Baylis, Sally A.
Schnierle, Barbara S.
Resumen
Chikungunya virus (CHIKV) is a mosquito-transmitted alphavirus that causes severe flu-like symptoms. The acute symptoms disappear after 1 week, but chronic arthralgia can persist for years. In this study, humoral immune responses in CHIKV-infected patients and vaccinees were analyzed. 2022-01-01